Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update

被引:51
|
作者
Ciarallo, Anthony [1 ]
Rivera, Juan [2 ]
机构
[1] McGill Univ, Hlth Ctr, Dept Med Imaging, Div Nucl Med, 1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada
[2] McGill Univ, Hlth Ctr, Dept Med, Div Endocrinol & Metab, Montreal, PQ, Canada
关键词
differentiated thyroid cancer; DTC; I-131; radioactive iodine therapy; RAI; thyroid cancer; RADIOIODINE-REMNANT ABLATION; I-131; METAANALYSIS; PATIENT;
D O I
10.2214/AJR.19.22626
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The paradigm of theranostics is based on tailoring therapy for the purpose of optimizing outcomes. This principle is being applied to radioactive iodine therapy. Consequently, thyroid cancer therapy protocols are evolving. The purpose of this article is to promote a modern approach to radioiodine therapy. CONCLUSION. This article highlights guidelines and position statements, summarizes the prognostication systems of thyroid cancer, and reviews which prescribed activities of I-131 are appropriate for each risk category.
引用
收藏
页码:285 / 291
页数:7
相关论文
共 50 条
  • [41] Radioactive iodine (131I) therapy for differentiated thyroid cancer in Japan: current issues with historical review and future perspective
    Tatsuya Higashi
    Takashi Kudo
    Seigo Kinuya
    Annals of Nuclear Medicine, 2012, 26 : 99 - 112
  • [42] Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic
    Tingting Qiao
    Dingwei Gao
    Junyu Tong
    Yun Shen
    Jiayue Ma
    Zhongwei Lv
    Dan Li
    Supportive Care in Cancer, 2022, 30 : 10169 - 10177
  • [43] Thyroglobulin levels before radioactive iodine therapy and dynamic risk stratification after 1 year in patients with differentiated thyroid cancer
    Bandeira, Leonardo
    Padovani, Rosalia do Prado
    Ticly, Ana Luiza
    Cury, Adriano Namo
    Scalissi, Nilza Maria
    Silveira Marone, Marilia Martins
    Ferraz, Carolina
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2017, 61 (06): : 590 - 599
  • [44] Radioactive iodine (131I) therapy for differentiated thyroid cancer in Japan: current issues with historical review and future perspective
    Higashi, Tatsuya
    Kudo, Takashi
    Kinuya, Seigo
    ANNALS OF NUCLEAR MEDICINE, 2012, 26 (02) : 99 - 112
  • [45] Mindfulness-based stress reduction in patients with differentiated thyroid cancer receiving radioactive iodine therapy: a randomized controlled trial
    Liu, Tianji
    Zhang, Wenqi
    Xiao, Shuai
    Xu, Lei
    Wen, Qiang
    Bai, Lin
    Ma, Qingjie
    Ji, Bin
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 467 - 474
  • [46] Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation
    Schmidt, Angelica
    Iglesias, Laura
    Klain, Michele
    Pitoia, Fabian
    Schlumberger, Martin J.
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2017, 61 (01): : 81 - 89
  • [47] Clinical, Pathological, and Molecular Profiling of Radioactive Iodine Refractory Differentiated Thyroid Cancer
    Shobab, Leila
    Gomes-Lima, Cristiane
    Zeymo, Alexander
    Feldman, Rebecca
    Jonklaas, Jacqueline
    Wartofsky, Leonard
    Burman, Kenneth D.
    THYROID, 2019, 29 (09) : 1262 - 1268
  • [48] Effect of Psychological Intervention on Differentiated Thyroid Cancer Patients in the Treatment with Radioactive Iodine
    Liu, Yan-Bin
    Zuo, Li-Juan
    Liu, Ya-Chao
    Li, Yan-Ping
    Xin, Yun-Chao
    Zhang, Hong-Yan
    Hou, Li -Yuan
    PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 731 - 738
  • [49] Radioactive Iodine Therapy in Differentiated Thyroid Cancer: Summary of the Korean Thyroid Association Guidelines 2024 from Nuclear Medicine Perspective, Part-II
    Oh, So Won
    Park, Sohyun
    Chong, Ari
    Kim, Keunyoung
    Bang, Ji-In
    Seo, Youngduk
    Hong, Chae Moon
    Lee, Sang-Woo
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 59 (01) : 8 - 26
  • [50] Association of the Cumulative Dose of Radioactive Iodine Therapy With Overall Survival in Patients With Differentiated Thyroid Cancer and Pulmonary Metastases
    Yang, Jing
    Zheng, Rong
    Liang, Meng
    Jia, Yingying
    Lin, Lin
    Gang, Jianhua
    Chen, Shengzu
    Li, Ye-Xiong
    FRONTIERS IN ONCOLOGY, 2019, 9